Lantern Pharma;Inc.

Lantern Pharma is a clinical-stage pharmaceutical company that uses artificial intelligence, machine learning, and genomics to develop precision oncology therapies. The company utilizes its RADR platform to identify patient populations most likely to respond to specific drug candidates, aiming to reduce the cost and timeline of drug discovery. Its current pipeline includes lead candidates LP-184, LP-284, and LP-300 targeting various cancers such as non-small cell lung cancer and DNA damage repair deficient tumors.